Skip to main content
. Author manuscript; available in PMC: 2011 Jun 15.
Published in final edited form as: Clin Cancer Res. 2010 Jun 1;16(12):3226–3231. doi: 10.1158/1078-0432.CCR-10-0321

Fig. 1.

Fig. 1

Immunoblots probed with NSCLC patient sera. A, Pooled serum blot: Ten individual serum samples from patients with stage I NSCLC were used to probe a blot containing the pooled sera from 5 late stage NSCLC patients. B, CFH blot: Individual stage I, stage III/IV and normal serum samples were used to probe a blot containing purified CFH.